TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
TechniScan's Warm Bath Ultrasound (WBU™) system is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the- art ultrasound technology is used in a warm water tank to capture images of the breast anatomy.
The Moores UCSD Cancer Center is a National Cancer Institute (NCI) designated comprehensive cancer center with scientists and clinicians focused on developing the next generation of cancer therapies and cures. The TechniScan Warm Bath Ultrasound™ system investigations will be conducted with Michael P. Andre, Ph.D., Professor of Radiology, and breast radiologists Dr. Linda Olson and Dr. Haydee Ojeda-Fournier.
Funded by a NCI Small Business Innovation Research Grant (SBIR) from the National Institute of Health, the study will involve approximately 130 women with various types of breast lesions. Major objectives of the 12-month study will be to compare WBU™ to conventional breast sonography and to examine the WBU™ system's ability to differentiate between normal, benign and malignant breast tissue.